Total (N=45) | |
Female sex | 41 (91.1%) |
Age (years) | 57 (49–66) |
Eye symptoms | 39 (86.7%) |
Oral symptoms | 41 (91.1%) |
ESSPRI | 6.0 (4.2–6.7) |
Use of artificial tears | 36 (80.0%) |
Systemic involvement (ESSDAI>0) | 28 (62.2%) |
ESSDAI score | 2.0 (1.0–4.0) |
Schirmer’s test <5 mm/5 min | 35 (77.8%) |
Abnormal ocular surface staining test | 27 (61.4%) |
Unstimulated whole salivary flow <1.5 mL/15 min | 33 (75.0%) |
Focal sialadenitis (focus score ≥1) | 40 (88.9%) |
Presence of anti-SSA antibodies | 36 (80.0%) |
Presence of anti-SSB antibodies | 17 (37.8%) |
Results are reported as N (%), or median (IQR).
ESSDAI, Eular Sjögren Syndrome Disease Activity Index; ESSPRI, EULAR Sjrogen's Syndrome Patient Reported Index.